Table 1.
Covariate | GlcCer median (IQR), μg/mL | PtdEtn median (IQR), μg/mL |
---|---|---|
Sex | ||
Female | 5.6 (4.9‐6.6) | 51.3 (38.2‐64.6) |
Male | 6.0 (5.3‐7.1) | 57.2 (43‐75.1) |
P value | .06 | .24 |
Age | ||
<35 | 5.5 (5.1‐6.4) | 45.7 (35.5‐59.1) |
35‐45 | 5.8 (4.8‐6.6) | 53.6 (38.7‐70.5) |
45‐55 | 5.9 (5.0‐7.3) | 60.6 (44.6‐70.1) |
≥55 | 5.6 (5.1‐6.7) | 56.7 (44.3‐66.4) |
P value | .39 | .13 |
Obesity | ||
Not obese | 5.9 (4.9‐6.9) | 53.6 (44.2‐65.0) |
Obese | 5.6 (4.4‐6.6) | 56.2 (46.2‐67.5) |
P value | .12 | .47 |
Factor V Leiden | ||
Yes | 5.1 (4.8‐6.6) | 42.0 (35.5‐91.5) |
No | 5.8 (5.0‐6.7) | 56.2 (42.0‐66.9) |
P value | .21 | .59 |
Prothrombin G20210A | ||
Yes | 5.5 (N=3) | 42.0 (N=3) |
No | 5.8 (5.0‐6.8) | 56.3 (42.0‐67.5) |
P value | .41 | .15 |
Hormone use | ||
Yes | 5.5 (5.0‐6.4) | 46.2 (37.0‐59.1) |
No | 5.7 (4.7‐6.7) | 59.0 (47.2‐67.3) |
P value | .62 | .02 |
VTE, venous thromboembolism.